Streptococcal infections of the skin and mucous membranes;Streptokokkeninfektionen der haut und schleimhäute

JDDG - Journal of the German Society of Dermatology

Volumn 5, Issue 6, 2007, Pages 527-532

  Tschachler, E ^a   Brockmeyer, N ^b   Effendy, I ^b   Geiss, H K ^b   Harder, S ^b   Hartmann, M ^b   Jappe, U ^b   Plettenberg, A ^b   Rasokat, H ^b   Reimann, H ^b   Shah, P ^b   Stcker, M ^b   Wichelhaus, T A ^b   Schofer H ^b  

^a Universitatsklinik fur Dermatologie   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

8 QUINOLINOL SULFATE; BETA LACTAMASE INHIBITOR; CEFALEXIN; CEFAZOLIN; CITRATE SODIUM; CLINDAMYCIN; CLIOQUINOL; DEQUALINIUM; ETHACRIDINE LACTATE; FUSIDATE SODIUM; FUSIDIC ACID; HYDROGEN PEROXIDE; INFECTOPYODERM; LEIODERM; LINOLA SEPT; MACROLIDE; PENICILLIN G; PENICILLIN V; POVIDONE IODINE; PSEUDOMONIC ACID; ROXITHROMYCIN; TURIXIN; TYROTHRICIN; UNCLASSIFIED DRUG;

ALLERGIC GLOMERULONEPHRITIS; ANTIGEN DETECTION; BACTERIUM CULTURE; BETA HEMOLYTIC STREPTOCOCCUS; BLISTER; CLINICAL FEATURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; ECTHYMA; ERYSIPELAS; GRAM POSITIVE COCCI; HUMAN; IMPETIGO; LYMPHANGITIS; MUCOSA; NECROTIZING FASCIITIS; PATHOGENESIS; REVIEW; SCARLET FEVER; SEROLOGY; SKIN; STREPTOCOCCUS INFECTION; TOXIC SHOCK SYNDROME;

ANTI-BACTERIAL AGENTS; DERMATOLOGY; DIAGNOSIS, DIFFERENTIAL; HUMANS; MUCOUS MEMBRANE; PHYSICIAN'S PRACTICE PATTERNS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS;

EID: 34250329204     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2007.06287.x     Document Type: Review

References (41)

1. Abeck D, Korting HC, Mempel M (1998) Pyodermien. Hautarzt 49: 243-252.
2. Abeck D, Mempel M, Seidl HP, Schnopp C, Ring J, Heeg K (2000) Impetigo contagiosa - Erregerspektrum und therapeutische Konsequenzen. Dtsch Med Wschr 125:1257-1259.
3. Abeck D, Strom K, Schnopp C, Korting HC, Heeg K (2001) Pyodermie-Ein interdisziplinäres Problem. Dt Ärztebl 98:2950-2960.
4. Allard P, Stücker M, Kobyletzki G von, el Gammal S, Altmeyer P (1999). Zyklische intravenöse Antibiose als effizientes Therapiekonzept des chronisch-rezidivierenden Erysipels. Hautarzt 50:34-38.
5. Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR (2000) Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nature Med 6:1275-1277.
6. Bass JW, Chan DS, Creamer KM, Thomson MW, Malone FJ, Becker TM, Marks SN (1997) Comparison of oral cephalexin, topical mupirocin and topical bacitracin for treatment of impetigo. Pediatr Inf Dis J 16:708-709.
7. Bisno AL, Stevens DL. Streptococcus pyogenes (2000) In: Mandell GL, Bennett JE, Dolin R (Hrsg.) Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 5th Edition, Philadelphia: Churchill Livingstone, Chapter 186, S 2101-2117.
8. Colsky AS, Kirsner RS, Kerdel FA (1998) Analysis of antibiotic susceptibilities of skin wound flora in hospitalized dermatology patients. Arch Dermatol 134:1006-1009.
9. Conference de Consesus: Erysipel et fasciite necrosante: pris en charge. (2000) Med. Mal. Infect. 30, Suppl. 4:252-272.
10. Crickx B (1993) Infections cutanées bactériennes: Erysipèle. Rev Prat 43: 876-78.
11. Dagan R, Bar-David Y (1992) Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 36:287-290.
12. Duvanel T, Merot Y, Harms M, Saurat J-H (1985) Prophylactic antibiotics in erysipelas. Lancet I, 1401.
13. Eriksson B, Jorup-Ronstrom C, Karkkonen K, Sjoblom AC, Holm SE (1996) Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clin Infect Dis. 23:1091-1108.
14. Espersen F (1998) Resistance to antibiotics used in dermatological practice. Br J Dermatol 139 Suppl 53:4-8.
15. Finlay BB, Falkow S (1997) Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev. 61:136-169.
16. Facklam R (2002) What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev. 15:613-630.
17. Gemmell CG (2001) Susceptibility of a variety of clinical isolates to linezolid: a European inter-country comparison. J Antimicrob Chemother 48:47-52.
18. Gilbert M (1989) Topical 2 % mupirocin versus 2 % fusidic acid ointment in the treatment of primary and secondary skin infections. J Am Acad Dermatol 20:1083-1087.
19. Gravet A, Couppie P, Meunier O, Clyti E, Moreau B, Pradinaud R, Monteil H, Prevost G (2001) Staphylococcus aureus isolated in cases of impetigo produces both epidermolysin A or B and LukE-LukD in 78 % of 131 retrospective and prospective cases. J Clin Microbiol 39:4349-4356.
20. Gunnarsson RK, Holm SE, Soderstrom M (1997) The prevalence of beta-haemolytic streptococci in throat specimens from healthy children and adults. Implications for the clinical value of throat cultures. Scand J Prim Health Care. 15:149-55.
21. Höger PH (1998) Topische Antibiotika und Antiseptika. Hautarzt 49:331-347.
22. Hollinger MA (1996) Toxicological aspects of topical silver pharmaceuticals. Crit Rev Toxicol 26:255-260.
23. Koning S, van Suijlekom-Smit LWA, Nouwen JL, Verduin CM, Bernsen RMD, Oranje AP, Thomas S, van der Wouden JC (2002) Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial. Primary Care 324:1-5.
24. Korting HC. Bakterielle Erkrankungen (1995) In Braun-Falco O, Plewig G, Wolff HH (Hrsg) Dermatologie und Venerologie. 4 Aufl. Berlin, Heidelberg, New York: Springer S 178-218.
25. Kremer M, Zuckerman R, Avraham Z, Raz R (1991) Long-term antimicrobial therapy in the prevention of recurrent soft-tissue infections. J Infect 22: 37-40.
26. McLinn S (1990) A bacteriologically controlled, randomized study comparing the efficacy of 2 % mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo. J Am Acad Dermatol 22:883-885.
27. Mead PB, Winn WC. (2000) Vaginal-rectal colonization with group A streptococci in late pregnancy. Infect Dis Obstet Gynecol 8:217-219.
28. Metz PM, Marshall DA, Eaglstein WH, Piovanetti Y, Montalvo J (1989) Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy. Arch Dermatol 125:1069-1073.
29. Norcross MC Jr, Mitchell DF (1993) Blistering distal dactylitis caused by Staphylococcus aureus. Cutis 51:353-354.
30. Ruoff KL (1995) Stretpococcus. In Manual of Clinical Microbiology. Eds. PR. Murray et al., ASM Press Washington, pp299-307.
31. Schofer H, Brockmeyer N, Dissemond J, Efendy I, Esser S, Geiss HK, Harder S, Hartmann M, Jappe U, Plettenberg A, Reimann H, Shah P, Tschachler E, Wichelhaus TA; Deutschen Dermatologischen Gesellschaft (DDG) Arbeitsgemeinschaft fur Dermatologische Infektiologie (ADI). [Staphylococcal infections of the skin and mucous membranes. Guideline of the German Dermatologic Society, Study Group of Dermatologic Infectiology] J Dtsch Dermatol Ges. 2005 Sep; 3(9): 726-34.
32. Seal DV. (2001) Necrotizing fasciitis. Curr Opin Infect Dis. 14:127-32.
33. Sjöblom AC, Eriksson B, Jorup-Rönström C, Karkkonen K, Lindqvist M (1993) Antibiotic Prophylaxis in Recurrent Erysipelas. Infection 21: 390-393.
34. Spelman D. Fusidic acid in skin and soft tissue infections. Int J Antimicrob Agents 1999; 12: Suppl. 2 (Sodium Fusidate Themenheft) S59-S66.
35. Stalder JF, Fleury M, Sourisse M et al (1992) Comparative effects of two topical antiseptics (chlorhexidine vs KMnO4) on bacterial skin flora in atopic dermatitis. Acta Dermatovenereol 176, Suppl:132-134.
36. Stücker M, Allard P, Altmeyer P (2003) Therapie des chronisch rezidivierenden Erysipels durch zyklische Antibiose. Derm 9: 203-209.
37. Sudarsky LA, Laschinger JC, Coppa GF, Spencer FC. (1987) Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann. Surg 206:661-665.
38. Thestrup-Pedersen K (1998) Bacteria and the skin: clinical practice and therapy update. Br J Dermatol 139:1-3.
39. Veien NK (1998) The clinician's choice of antibiotics in the treatment of bacterial skin infection. Br J Dermatol 139 Suppl 53:30-36.
40. Watcher MA, Wheeland RG (1989) The role of topical agents in the healing of full-thickness wounds. J Dermatol Surg Oncol 15:1188-1195.
41. Wilkinson JD (1998) Fusidic acid in Dermatology. Br J Dermatol 139 Suppl:37-40.